Fsr-Independent Production of Protease(s) May Explain the Lack of Attenuation of an Enterococcus faecalis fsr Mutant Versus a gelE-sprE Mutant in Induction of Endocarditis
暂无分享,去创建一个
Kavindra V. Singh | B. Murray | Barbara E. Murray | Sreedhar R. Nallapareddy | Esteban C. Nannini | E. Nannini | S. R. Nallapareddy | Kavindra V. Singh
[1] A. Tarkowski,et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model , 1993, Infection and immunity.
[2] E. Gutschik,et al. EXPERIMENTAL ENDOCARDITIS IN RABBITS. , 1980, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.
[3] G. Eliopoulos,et al. In Vivo Activities of Evernimicin (SCH 27899) against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci in Experimental Endocarditis , 2000, Antimicrobial Agents and Chemotherapy.
[4] C. Wolz,et al. Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus , 1995, Journal of bacteriology.
[5] F. Ausubel,et al. Contribution of Gelatinase, Serine Protease, and fsr to the Pathogenesis of Enterococcus faecalis Endophthalmitis , 2004, Infection and Immunity.
[6] Frederick M. Ausubel,et al. Virulence Effect of Enterococcus faecalis Protease Genes and the Quorum-Sensing Locus fsr in Caenorhabditis elegans and Mice , 2002, Infection and Immunity.
[7] G. Weinstock,et al. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function , 1993, Journal of bacteriology.
[8] Y. Su,et al. Nucleotide sequence of the gelatinase gene (gelE) from Enterococcus faecalis subsp. liquefaciens , 1991, Infection and immunity.
[9] M. Levison,et al. Rat model of experimental endocarditis , 1978, Infection and immunity.
[10] G. Weinstock,et al. Translocation of Enterococcus faecalis Strains across a Monolayer of Polarized Human Enterocyte-Like T84 Cells , 2004, Journal of Clinical Microbiology.
[11] S. Ehrlich,et al. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. , 2001, Genome research.
[12] F. Ausubel,et al. A simple model host for identifying Gram-positive virulence factors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[14] J. Potempa,et al. Molecular Diversity of a Putative Virulence Factor: Purification and Characterization of Isoforms of an Extracellular Serine Glutamyl Endopeptidase of Enterococcus faecalis with Different Enzymatic Activities , 2005, Journal of bacteriology.
[15] J. Nakayama,et al. Description of a 23.9-Kilobase Chromosomal Deletion Containing a Region Encoding fsr Genes Which Mainly Determines the Gelatinase-Negative Phenotype of Clinical Isolates of Enterococcus faecalis in Urine , 2002, Applied and Environmental Microbiology.
[16] G. Weinstock,et al. Characterization of fsr, a Regulator Controlling Expression of Gelatinase and Serine Protease inEnterococcus faecalis OG1RF , 2001, Journal of bacteriology.
[17] C. Waters,et al. Role of the Enterococcus faecalis GelE Protease in Determination of Cellular Chain Length, Supernatant Pheromone Levels, and Degradation of Fibrin and Misfolded Surface Proteins , 2003, Journal of bacteriology.
[18] L. Hancock,et al. The Enterococcus faecalis fsr Two-Component System Controls Biofilm Development through Production of Gelatinase , 2004, Journal of bacteriology.
[19] B. Murray,et al. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. , 1995, The Journal of infectious diseases.
[20] Kavindra V. Singh,et al. Molecular Epidemiology of the fsr Locus and of Gelatinase Production among Different Subsets of Enterococcus faecalis Isolates , 2004, Journal of Clinical Microbiology.
[21] G. Weinstock,et al. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. , 1998, The Journal of infectious diseases.
[22] P. Trieu-Cuot,et al. A broad-host-range mobilizable shuttle vector for the construction of transcriptional fusions to beta-galactosidase in gram-positive bacteria. , 1997, FEMS microbiology letters.
[23] A. Cheung,et al. Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits , 1994, Infection and immunity.
[24] F. Teng,et al. Influence of Origin of Isolates, Especially Endocarditis Isolates, and Various Genes on Biofilm Formation by Enterococcus faecalis , 2004, Infection and Immunity.
[25] W. D. de Vos,et al. Gelatinase biosynthesis‐activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis , 2001, Molecular microbiology.
[26] Robin Patel,et al. Linezolid Therapy of Vancomycin-ResistantEnterococcus faecium Experimental Endocarditis , 2001, Antimicrobial Agents and Chemotherapy.
[27] G. Weinstock,et al. Effects of Enterococcus faecalis fsrGenes on Production of Gelatinase and a Serine Protease and Virulence , 2000, Infection and Immunity.
[28] Yung-Hua Li,et al. Esp-Independent Biofilm Formation by Enterococcus faecalis , 2004, Journal of bacteriology.
[29] In Vivo Efficacy and Pharmacokinetics of AC98-6446, a Novel Cyclic Glycopeptide, in Experimental Infection Models , 2004, Antimicrobial Agents and Chemotherapy.
[30] R. Novick. Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.
[31] F. Teng,et al. Importance of gls24 in virulence and stress response of Enterococcus faecalis and use of the Gls24 protein as a possible immunotherapy target. , 2005, The Journal of infectious diseases.
[32] F. Ausubel,et al. The Enterococcus faecalis fsrB Gene, a Key Component of the fsr Quorum-Sensing System, Is Associated with Virulence in the Rabbit Endophthalmitis Model , 2002, Infection and Immunity.
[33] G. Weinstock,et al. Effect of Disruption of a Gene Encoding an Autolysin of Enterococcus faecalis OG1RF , 1998, Antimicrobial Agents and Chemotherapy.